Showing 1 - 1 results of 1 for search 'Thomas P Miller', query time: 0.02s Refine Results
  1. 1
    Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2.

    Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2. by Daruka Mahadevan, Carla Morales, Laurence S Cooke, Ann Manziello, David W Mount, Daniel O Persky, Richard I Fisher, Thomas P Miller, Wenqing Qi

    Published 2014-01-01
    Get full text
    Article

Search Tools: